December 2015

New Product - Vimizim

Vimizim (elosulfase alfa (rch)) is a purified recombinant human N‑acetylgalactosamine‑6‑sulfatase enzyme. Vimizim is indicated for the treatment of mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome). Vimizim is available as a 5 mL concentrate for infusion delivering 5 mg elosulfase alfa in packs of 1’s.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au